Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 61

Sort by

Sort Order Select

Journal Articles

Novel Evidence That the Mannan-Binding Lectin (MBL) Pathway of Complement Activation Plays a Pivotal Role in Triggering Mobilization of Hematopoietic Stem/Progenitor Cells By Activation of Both the Complement and Coagulation Cascades

Mateusz Adamiak, Malwina Suszynska, PhD, Ahmed Abdel-Latif, MD PhD, Ahmed Abdelbaset-Ismail, PhD, Janina Ratajczak, MD PhD, Magdalena Kucia, PhD, Mariusz Z Ratajczak, MD PhD

Blood (2016) 128 (22): 3371.

https://doi.org/10.1182/blood.V128.22.3371.3371

Published: 2016

Journal Articles

Inappropriate Listing of Heparin As an Allergy in the Electronic Medical Record Due to Misdiagnosis of Heparin-Induced Thrombocytopenia: Frequency and Consequences

Christine M. McMahon, MD, Adam Cuker, MD MS

Blood (2015) 126 (23): 3479.

https://doi.org/10.1182/blood.V126.23.3479.3479

Published: 2015

Journal Articles

Heparin Re-Exposure in Patients with Heparin-Induced Thrombocytopenia (HIT)

Prajwal Dhakal, M.B.B.S, Vijaya R. Bhatt, MBBS

Blood (2014) 124 (21): 4265.

https://doi.org/10.1182/blood.V124.21.4265.4265

Published: 2014

Journal Articles

A Novel C5 Complement Inhibitor Protects Against Sepsis-Induced Activation of Complement, Coagulation and Inflammation and Provides Survival Benefit in E. coli Sepsis

Ravi Keshari, PhD, Robert Silasi-Mansat, PhD, Narcis I. Popescu, PhD, Hala Chaaban, MD, Cristina Lupu, PhD, Steven J DeMarco, PhD, Florea Lupu, PhD

Blood (2014) 124 (21): 112.

https://doi.org/10.1182/blood.V124.21.112.112

Published: 2014

Journal Articles

Novel Evidence That Crosstalk Between Three Evolutionarily Ancient Proteolytic Enzyme Cascades (coagulation, fibrinolysis, and complement) Plays An Important Role In Mobilization Of Hematopoietic Stem/Progenitor Cells (HSPCs)

Sylwia Borkowska, MS, Malwina Suszynska, MS, Katarzyna Mierzejewska, PhD, Marta Budkowska, MS, Daria Salata, MS, Barbara Dolegowska, PhD, Janina Ratajczak, MD, PhD, Magdalena Kucia, Ph.D., Mariusz Z Ratajczak, MD, PhD

Blood (2013) 122 (21): 903.

https://doi.org/10.1182/blood.V122.21.903.903

Published: 2013

Journal Articles

Incidence of Direct Thrombin Inhibitor Therapy for Presumed Heparin Induced Thrombocytopenia Before and After Implementation of Heparin Induced Thrombocytopenia IgG Subtype Antibody Test

Randall R Ingham, II, MD, John L. Reagan, MD, Samir Dalia, MD, Joseph D. Sweeney, MD, James N. Butera, MD

Blood (2012) 120 (21): 3336.

https://doi.org/10.1182/blood.V120.21.3336.3336

Published: 2012

Journal Articles

Validation of the Use of Apixaban As an Alternate Anticoagulant for the Management of Patients with Heparin-Induced Thrombocytopenia.

Jeanine M. Walenga, PhD, Margaret Prechel, Debra Hoppensteadt, Vicki Escalante, BS, Talhah Chaudhry, Walter Jeske, PhD, Mamdouh Bakhos, MD

Blood (2012) 120 (21): 2265.

https://doi.org/10.1182/blood.V120.21.2265.2265

Published: 2012

Journal Articles

Effect of New Direct Oral Anticoagulants on Ex Vivo Platelet and Fibrin Thrombus Formation in Blood Flowing Over Fibrillar Type I Collagen

Grazia Loredana Mendolicchio, MD, PhD, Corrado Lodigiani, MD, Monica Bacci, Marco Scardino, MD, Carlo Ferrari Matteo, MD, Grappiolo Guido, MD, Lidia Rota, MD, Zaverio M. Ruggeri, MD

Blood (2011) 118 (21): 2318.

https://doi.org/10.1182/blood.V118.21.2318.2318

Published: 2011

Journal Articles

VTE Prophylaxis with Desirudin in Patients with Thrombocytopenia: Insights From the DESIRABLE Trial,

Jerrold H Levy, MD, Nigel S. Key, MBChB, Andrew F Shorr, MD, MPH, Michael A Kurz, PhD, Victor J. Marder, M.D.

Blood (2011) 118 (21): 3293.

https://doi.org/10.1182/blood.V118.21.3293.3293

Published: 2011

Journal Articles

Distinct Roles of the Extrinsic and the Intrinsic Coagulation Pathways In Different Murine Thrombosis Models,

Antonella Zampolli, PhD, Patrizia Marchese, PhD, Andras Gruber, MD, Wolfram Ruf, MD, Zaverio M. Ruggeri, MD

Blood (2011) 118 (21): 3278.

https://doi.org/10.1182/blood.V118.21.3278.3278

Published: 2011

Journal Articles

Cross Reactivity of Natural Hirudin Compared to the Recombinant Hirudins with Sheep Anti Hirudin Antibody

Vijaya L Paramatmuni, Debra Hoppensteadt, Ph.D., Saayi Setty, Evangelos Litinas, MD, Nasir Sadeghi, Jawed Fareed, PhD

Blood (2011) 118 (21): 4321.

https://doi.org/10.1182/blood.V118.21.4321.4321

Published: 2011

Journal Articles

Evaluation of Anticoagulant Drugs with TF-Induced Thrombin Generation: An In Vitro comparative Study In Platelet-Rich Plasma (PRP) Versus Platelet-Poor Plasma (PPP)

Severine Robert, François Mullier, Nicolas Lufin, Philippe Devel, Bernard Chatelain, Jean-Michel Dogné

Blood (2010) 116 (21): 3335.

https://doi.org/10.1182/blood.V116.21.3335.3335

Published: 2010

Journal Articles

Evaluation of the Pre-Test Scoring System (4Ts) for the Evaluation and Management of Heparin Induced Thrombocytopenia

Rodina Vatanparast, MD, Prasad Pillai, MD, Gregory Crane, MD, Steven Minter, DO, Kristine Ward, MD, David Topolsky, MD, Michael Styler, MD, Pamela Ann Crilley, DO

Blood (2010) 116 (21): 2551.

https://doi.org/10.1182/blood.V116.21.2551.2551

Published: 2010

Journal Articles

Lack of Clinically Significant Interactions Between the Subcutaneously Administered Direct Thrombin Inhibitor Desirudin and Orally Administered Warfarin Upon the International Normalized Ratio.

Jerrold Levy, MD, Michael Kurz, PhD, Andrew Whelton, MD

Blood (2009) 114 (22): 3131.

https://doi.org/10.1182/blood.V114.22.3131.3131

Published: 2009

Journal Articles

Treatment of Heparin-Induced Thrombocytopenia and Associated Thromboses with Fondaparinux.

Amelia Chan, PharmD, Daniel Egan, Heather Landau, MD, Hani Hassoun, MD

Blood (2009) 114 (22): 2096.

https://doi.org/10.1182/blood.V114.22.2096.2096

Published: 2009

Journal Articles

Dosing lepirudin in patients with heparin-induced thrombocytopenia and normal or impaired renal function: a single-center experience with 68 patients

Martina Tschudi, Bernhard Lämmle, Lorenzo Alberio

Blood (2009) 113 (11): 2402–2409.

https://doi.org/10.1182/blood-2008-07-162271

Published: 2009

Journal Articles

Comparative Antithrombotic and Antihemostatic Effects of the Direct Factor Xa Inhibitors, Apixaban and Rivaroxaban, and the Direct Thrombin Inhibitors, Dabigatran and Lepirudin, in Rabbit Models of Venous Thrombosis and Bleeding Time

Pancras C. Wong, PhD, Earl Crain, Jr., Carol Watson

Blood (2008) 112 (11): 3025.

https://doi.org/10.1182/blood.V112.11.3025.3025

Published: 2008

Journal Articles

The Influence of Lepirudin, Bivalirudin and Dabigatran on the Calibrated Automated Thrombogram (CAT)

Barry J Woodhams, Audrey Carlo, Lena Le Flem, Celine Guinet, Francois Depasse, Michel Meyer Samama

Blood (2008) 112 (11): 4055.

https://doi.org/10.1182/blood.V112.11.4055.4055

Published: 2008

Journal Articles

The Cost of HIT-Safe Anticoagulant Use at a Tertiary Care, Adult, Academic Hospital.

Natasha Nanwa, MSc, Nicole Mittmann, MSc, PhD, Sandra Knowles, BScPhm, Claudia Bucci, BScPhm, PharmD, Rita Selby, MBBS, FRCPC, Neil Shear, MD, FRCPC, Scott Walker, MScPhm, William H. Geerts, MD, FRCPC

Blood (2008) 112 (11): 1293.

https://doi.org/10.1182/blood.V112.11.1293.1293

Published: 2008

Journal Articles

Retrospective Cost Analysis of Testing for HIT Antibodies in a Community Hospital

Raimonda Goldman, Berry Ustun, MD, Randy L. Levine, MD

Blood (2008) 112 (11): 4544.

https://doi.org/10.1182/blood.V112.11.4544.4544

Published: 2008

NARROW

Novel Evidence That the Mannan-Binding Lectin (MBL) Pathway of Complement Activation Plays a Pivotal Role in Triggering Mobilization of Hematopoietic Stem/Progenitor Cells By Activation of Both the Complement and Coagulation Cascades

Inappropriate Listing of Heparin As an Allergy in the Electronic Medical Record Due to Misdiagnosis of Heparin-Induced Thrombocytopenia: Frequency and Consequences

Heparin Re-Exposure in Patients with Heparin-Induced Thrombocytopenia (HIT)

A Novel C5 Complement Inhibitor Protects Against Sepsis-Induced Activation of Complement, Coagulation and Inflammation and Provides Survival Benefit in E. coli Sepsis

Novel Evidence That Crosstalk Between Three Evolutionarily Ancient Proteolytic Enzyme Cascades (coagulation, fibrinolysis, and complement) Plays An Important Role In Mobilization Of Hematopoietic Stem/Progenitor Cells (HSPCs)

Incidence of Direct Thrombin Inhibitor Therapy for Presumed Heparin Induced Thrombocytopenia Before and After Implementation of Heparin Induced Thrombocytopenia IgG Subtype Antibody Test

Validation of the Use of Apixaban As an Alternate Anticoagulant for the Management of Patients with Heparin-Induced Thrombocytopenia.

Effect of New Direct Oral Anticoagulants on Ex Vivo Platelet and Fibrin Thrombus Formation in Blood Flowing Over Fibrillar Type I Collagen

VTE Prophylaxis with Desirudin in Patients with Thrombocytopenia: Insights From the DESIRABLE Trial,

Distinct Roles of the Extrinsic and the Intrinsic Coagulation Pathways In Different Murine Thrombosis Models,

Cross Reactivity of Natural Hirudin Compared to the Recombinant Hirudins with Sheep Anti Hirudin Antibody

Evaluation of Anticoagulant Drugs with TF-Induced Thrombin Generation: An In Vitro comparative Study In Platelet-Rich Plasma (PRP) Versus Platelet-Poor Plasma (PPP)

Evaluation of the Pre-Test Scoring System (4Ts) for the Evaluation and Management of Heparin Induced Thrombocytopenia

Lack of Clinically Significant Interactions Between the Subcutaneously Administered Direct Thrombin Inhibitor Desirudin and Orally Administered Warfarin Upon the International Normalized Ratio.

Treatment of Heparin-Induced Thrombocytopenia and Associated Thromboses with Fondaparinux.

Dosing lepirudin in patients with heparin-induced thrombocytopenia and normal or impaired renal function: a single-center experience with 68 patients

Comparative Antithrombotic and Antihemostatic Effects of the Direct Factor Xa Inhibitors, Apixaban and Rivaroxaban, and the Direct Thrombin Inhibitors, Dabigatran and Lepirudin, in Rabbit Models of Venous Thrombosis and Bleeding Time

The Influence of Lepirudin, Bivalirudin and Dabigatran on the Calibrated Automated Thrombogram (CAT)

The Cost of HIT-Safe Anticoagulant Use at a Tertiary Care, Adult, Academic Hospital.

Retrospective Cost Analysis of Testing for HIT Antibodies in a Community Hospital

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only